Cargando…

The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome

BACKGROUND: Multiple organ dysfunction syndrome (MODS) and the consecutive multiple organ failure (MOF) are severe and dreaded complications with a high mortality in multiple trauma patients. The aim of this study was to investigate the potential of the adipokines leptin, resistin, interleukin-17A a...

Descripción completa

Detalles Bibliográficos
Autores principales: Haupt, Julian, Krysiak, Niels, Unger, Marina, Bogner-Flatz, Viktoria, Biberthaler, Peter, Hanschen, Marc, van Griensven, Martijn, Haug, Alexander T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086117/
https://www.ncbi.nlm.nih.gov/pubmed/33931112
http://dx.doi.org/10.1186/s40001-021-00511-z
_version_ 1783686461105635328
author Haupt, Julian
Krysiak, Niels
Unger, Marina
Bogner-Flatz, Viktoria
Biberthaler, Peter
Hanschen, Marc
van Griensven, Martijn
Haug, Alexander T.
author_facet Haupt, Julian
Krysiak, Niels
Unger, Marina
Bogner-Flatz, Viktoria
Biberthaler, Peter
Hanschen, Marc
van Griensven, Martijn
Haug, Alexander T.
author_sort Haupt, Julian
collection PubMed
description BACKGROUND: Multiple organ dysfunction syndrome (MODS) and the consecutive multiple organ failure (MOF) are severe and dreaded complications with a high mortality in multiple trauma patients. The aim of this study was to investigate the potential of the adipokines leptin, resistin, interleukin-17A and interleukin-33 as possible biomarkers in the early posttraumatic inflammatory response and for identifying severely traumatized patients at risk of developing MODS. METHODS: In total, 14 multiple trauma patients with an injury severity score (ISS) ≥ 16 as well as a control group of 14 non-multiple trauma patients were included in this study and blood samples were taken at the time points 0, 6, 24, 48 and 72 h after admission. For the trauma patients, the SIRS and Denver MOF score were determined daily. The quantitative measurement of the plasma concentrations of the adipokines was performed using ELISA. RESULTS: In the statistical analysis, the multiple trauma patients showed statistically significant higher plasma concentrations of leptin, resistin, IL-17A and IL-33 compared to the control group. In addition, there was a statistically significant positive correlation between the concentrations of resistin, IL-17A and IL-33 and the corresponding SIRS scores and between the concentrations of resistin, IL-17A and IL-33 and the corresponding Denver MOF scores. Finally, ROC curve analysis revealed that the adipokines leptin and IL-17A are suitable diagnostic markers for the discrimination between multiple trauma patients with and without MOF. CONCLUSIONS: Leptin and IL-17A could be suitable diagnostic markers to identify severely injured patients with a developing SIRS and MOF earlier, to adjust surgical therapy planning and intensive care.
format Online
Article
Text
id pubmed-8086117
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80861172021-04-30 The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome Haupt, Julian Krysiak, Niels Unger, Marina Bogner-Flatz, Viktoria Biberthaler, Peter Hanschen, Marc van Griensven, Martijn Haug, Alexander T. Eur J Med Res Research BACKGROUND: Multiple organ dysfunction syndrome (MODS) and the consecutive multiple organ failure (MOF) are severe and dreaded complications with a high mortality in multiple trauma patients. The aim of this study was to investigate the potential of the adipokines leptin, resistin, interleukin-17A and interleukin-33 as possible biomarkers in the early posttraumatic inflammatory response and for identifying severely traumatized patients at risk of developing MODS. METHODS: In total, 14 multiple trauma patients with an injury severity score (ISS) ≥ 16 as well as a control group of 14 non-multiple trauma patients were included in this study and blood samples were taken at the time points 0, 6, 24, 48 and 72 h after admission. For the trauma patients, the SIRS and Denver MOF score were determined daily. The quantitative measurement of the plasma concentrations of the adipokines was performed using ELISA. RESULTS: In the statistical analysis, the multiple trauma patients showed statistically significant higher plasma concentrations of leptin, resistin, IL-17A and IL-33 compared to the control group. In addition, there was a statistically significant positive correlation between the concentrations of resistin, IL-17A and IL-33 and the corresponding SIRS scores and between the concentrations of resistin, IL-17A and IL-33 and the corresponding Denver MOF scores. Finally, ROC curve analysis revealed that the adipokines leptin and IL-17A are suitable diagnostic markers for the discrimination between multiple trauma patients with and without MOF. CONCLUSIONS: Leptin and IL-17A could be suitable diagnostic markers to identify severely injured patients with a developing SIRS and MOF earlier, to adjust surgical therapy planning and intensive care. BioMed Central 2021-04-30 /pmc/articles/PMC8086117/ /pubmed/33931112 http://dx.doi.org/10.1186/s40001-021-00511-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Haupt, Julian
Krysiak, Niels
Unger, Marina
Bogner-Flatz, Viktoria
Biberthaler, Peter
Hanschen, Marc
van Griensven, Martijn
Haug, Alexander T.
The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
title The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
title_full The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
title_fullStr The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
title_full_unstemmed The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
title_short The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
title_sort potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086117/
https://www.ncbi.nlm.nih.gov/pubmed/33931112
http://dx.doi.org/10.1186/s40001-021-00511-z
work_keys_str_mv AT hauptjulian thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT krysiakniels thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT ungermarina thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT bognerflatzviktoria thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT biberthalerpeter thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT hanschenmarc thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT vangriensvenmartijn thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT haugalexandert thepotentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT hauptjulian potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT krysiakniels potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT ungermarina potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT bognerflatzviktoria potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT biberthalerpeter potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT hanschenmarc potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT vangriensvenmartijn potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome
AT haugalexandert potentialofadipokinesinidentifyingmultipletraumapatientsatriskofdevelopingmultipleorgandysfunctionsyndrome